Acta Oncologica, Volume 55, Issue 3 (2016)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Acta Oncologica, Volume 55, Issue 3 (2016)

See all volumes and issues
Vol 62, 2023 Vol 61, 2022 Vol 60, 2021 Vol 59, 2020 Vol 58, 2019 Vol 57, 2018 Vol 56, 2017 Volume 55, 2016 Vol 54, 2015 Vol 53, 2014 Vol 52, 2013 Vol 51, 2012 Vol 50, 2011 Vol 49, 2010 Vol 48, 2009 Vol 47, 2008 Vol 46, 2007 Vol 45, 2006 Vol 44, 2005 Vol 43, 2004 Vol 42, 2003 Vol 41, 2002 Vol 40, 2001 Vol 39, 2000 Vol 38, 1999 Vol 37, 1998 Vol 36, 1997 Vol 35, 1996 Vol 34, 1995 Vol 33, 1994 Vol 32, 1993 Vol 31, 1992 Vol 30, 1991 Vol 29, 1990 Vol 28, 1989 Vol 27, 1988 Vol 26, 1987 Vol 25, 1986 Vol 24, 1985 Vol 23, 1984 Vol 22, 1983 Vol 21, 1982 Vol 20, 1981 Vol 19, 1980 Vol 18, 1979 Vol 17, 1978 Vol 16, 1977 Vol 15, 1976 Vol 14, 1975 Vol 13, 1974 Vol 12, 1973 Vol 11, 1972 Vol 10, 1971 Vol 9, 1970 Vol 8, 1969 Vol 7, 1968 Vol 6, 1967 Vol 5, 1966 Vol 4, 1966 Vol 3, 1965 Vol 2, 1964 Vol 1, 1963
Download citations Download PDFs Download issue

EDITORIAL

Editorial
Any progress in pancreatic cancer?
Bengt Glimelius
Pages: 255-258
Published online: 17 Feb 2016
First Page PreviewforAny progress in pancreatic cancer? | Full Text | References | PDF (280.8 KB)
  • 1730 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

ORIGINAL ARTICLE: Gastrointestinal cancer

Article
Does long-term survival exist in pancreatic adenocarcinoma?
Myrte Zijlstra, Nienke Bernards, Ignace H. J. T. de Hingh, Agnes J. van de Wouw, Swan Hoo Goey, Esther M. G. Jacobs, Valery E. P. P. Lemmens & Geert-Jan Creemers
Pages: 259-264
Published online: 11 Nov 2015
AbstractforDoes long-term survival exist in pancreatic adenocarcinoma? | Full Text | References | PDF (616.3 KB)
  • 2238 Views
  • 20 CrossRef citations
  • 0Altmetric
Free Access
Article
Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma – A population-based cohort study
Knut J. Labori, Matthew H. Katz, Ching W. Tzeng, Bjørn A. Bjørnbeth, Milada Cvancarova, Bjørn Edwin, Elin H. Kure, Tor J. Eide, Svein Dueland, Trond Buanes & Ivar P. Gladhaug
Pages: 265-277
Published online: 25 Jul 2015
AbstractforImpact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma – A population-based cohort study | Full Text | References | PDF (817.4 KB)
  • 2348 Views
  • 108 CrossRef citations
  • 0Altmetric
Free Access
Article
Pancreatic cancer surgery in elderly patients: Balancing between short-term harm and long-term benefit. A population-based study in the Netherlands
Lydia G. M. van der Geest, Marc G. H. Besselink, Yvette R. B. M. van Gestel, Olivier R. C. Busch, Ignace H. J. T. de Hingh, Koert P. de Jong, I. Quintus Molenaar & Valery E. P. P. Lemmens
Pages: 278-285
Published online: 09 Nov 2015
AbstractforPancreatic cancer surgery in elderly patients: Balancing between short-term harm and long-term benefit. A population-based study in the Netherlands | Full Text | References | PDF (760.4 KB)
  • 2935 Views
  • 52 CrossRef citations
  • 0Altmetric
Free Access
Article
Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer
Jacob Elebro, Liv Ben Dror, Margareta Heby, Björn Nodin, Karin Jirström & Jakob Eberhard
Pages: 286-296
Published online: 11 Sep 2015
AbstractforPrognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer | Full Text | References | PDF (2.1 MB) | Supplemental
  • 1495 Views
  • 13 CrossRef citations
  • 0Altmetric
Open Access
Article
Staging and therapy for patients with hepatocellular cancer in a defined population from 2000 to 2011 – active palliative treatment improved overall survival
Per Lindnér, Erik Holmberg, Magnus Rizell & Larsolof Hafström
Pages: 297-302
Published online: 01 Oct 2015
AbstractforStaging and therapy for patients with hepatocellular cancer in a defined population from 2000 to 2011 – active palliative treatment improved overall survival | Full Text | References | PDF (743.5 KB)
  • 860 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer
Talha Shaikh, Mark A. Zaki, Michael M. Dominello, Elizabeth Handorf, Andre A. Konski, Steven J. Cohen, Anthony Shields, Philip Philip & Joshua E. Meyer
Pages: 303-308
Published online: 19 Nov 2015
AbstractforPatterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer | Full Text | References | PDF (609.4 KB) | Supplemental
  • 1105 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK)
Mayuko Saito, Kentaro Yamashita, Yoshiaki Arimura, Hiroyuki Kaneto, Hiroyuki Okuda, Masanori Nojima, Takeshi Hagiwara, Kazuya Suzuki, Takeya Adachi, Akira Goto, Kohei Nakachi, Atsushi Yawata, Mitsuru Yoshimoto, Tokuma Tanuma, Yasushi Adachi, Satoshi Yamaoka, Tsunenori Mizukoshi, Mariko Kawayama, Yasuo Hamamoto & Yasuhisa Shinomura
Pages: 309-317
Published online: 12 Jan 2016
AbstractforSerum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK) | Full Text | References | PDF (1.5 MB)
  • 1384 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Article
The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance
Bettina Butzke, Fuat S. Oduncu, Franziska Severin, Arne Pfeufer, Volker Heinemann, Clemens Giessen-Jung, Björn Stollenwerk & Wolf H. Rogowski
Pages: 318-328
Published online: 22 Jun 2015
AbstractforThe cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance | Full Text | References | PDF (1.1 MB) | Supplemental
  • 2104 Views
  • 24 CrossRef citations
  • 0Altmetric
Free Access

ORIGINAL ARTICLE: Urologic cancer

Article
Prognostic factors in second-line targeted therapy for metastatic clear-cell renal cell carcinoma after progression on an anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor
Anne Sacré, Philippe Barthélémy, Clement Korenbaum, Mickael Burgy, Pascal Wolter, Herlinde Dumez, Evelyne Lerut, Tine Loyson, Steven Joniau, Raymond Oyen, Philip R. Debruyne, Patrick Schöffski & Benoit Beuselinck
Pages: 329-340
Published online: 23 Oct 2015
AbstractforPrognostic factors in second-line targeted therapy for metastatic clear-cell renal cell carcinoma after progression on an anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor | Full Text | References | PDF (1.2 MB)
  • 1369 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Article
A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2
Anne V. Soerensen, Poul F. Geertsen, Ib J. Christensen, Gregers G. Hermann, Niels V. Jensen, Kirsten Fode, Astrid Petersen, Rickard Sandin & Frede Donskov
Pages: 341-348
Published online: 08 Oct 2015
AbstractforA five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2 | Full Text | References | PDF (1,009.5 KB) | Supplemental
  • 1092 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Article
Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients
Elisabeth Beisland, Hans J. Aarstad, Anne K. H. Aarstad, August Bakke, Leif Bostad & Christian Beisland
Pages: 349-356
Published online: 07 Aug 2015
AbstractforDevelopment of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients | Full Text | References | PDF (349.9 KB)
  • 1632 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

ORIGINAL ARTICLE: Thyroid cancer

Article
Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma
Päivi Siironen, Jaana Hagström, Hanna O. Mäenpää, Johanna Louhimo, Johanna Arola & Caj Haglund
Pages: 357-364
Published online: 04 Sep 2015
AbstractforLymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma | Full Text | References | PDF (285.6 KB)
  • 2795 Views
  • 20 CrossRef citations
  • 0Altmetric
Free Access
Article
Determinants of long-term quality of life in patients with differentiated thyroid carcinoma – a population-based cohort study in Sweden
Christel Hedman, Therese Djärv, Peter Strang & Catharina Ihre Lundgren
Pages: 365-369
Published online: 05 Nov 2015
AbstractforDeterminants of long-term quality of life in patients with differentiated thyroid carcinoma – a population-based cohort study in Sweden | Full Text | References | PDF (431.5 KB)
  • 2080 Views
  • 59 CrossRef citations
  • 0Altmetric
Free Access

ORIGINAL ARTICLE: Epidemiology

Article
Incidence of cancer among grand multiparous women in Finland with special focus on non-gynaecological cancers: A population-based cohort study
Emma Högnäs, Antti Kauppila, Marianne Hinkula, Juha S. Tapanainen & Eero Pukkala
Pages: 370-376
Published online: 28 Jul 2015
AbstractforIncidence of cancer among grand multiparous women in Finland with special focus on non-gynaecological cancers: A population-based cohort study | Full Text | References | PDF (466 KB)
  • 2290 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

LETTERS TO THE EDITOR

Letter
BRCA-associated pancreatico-biliary neoplasms: Four cases illustrating the emerging clinical impact of genotyping
Maja Bendtsen Sharma, Andreas Carus, Lone Sunde, Stephen Hamilton-Dutoit & Morten Ladekarl
Pages: 377-381
Published online: 23 May 2015
First Page PreviewforBRCA-associated pancreatico-biliary neoplasms: Four cases illustrating the emerging clinical impact of genotyping | Full Text | References | PDF (4.9 MB) | Supplemental
  • 1705 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access
Letter
Gemcitabine, capecitabine and oxaliplatin with or without cetuximab in advanced biliary tract carcinoma
Finn Ole Larsen, Dan Taksony Solyom Hoegdall, Estrid Hoegdall & Dorte Nielsen
Pages: 382-385
Published online: 12 Sep 2015
First Page PreviewforGemcitabine, capecitabine and oxaliplatin with or without cetuximab in advanced biliary tract carcinoma | Full Text | References | PDF (355.7 KB)
  • 1191 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access
Letter
Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study
Hugo J. A. Adams, John M. H. de Klerk, Rob Fijnheer, Ben G. F. Heggelman, Stefan V. Dubois, Rutger A. J. Nievelstein & Thomas C. Kwee
Pages: 386-390
Published online: 15 May 2015
First Page PreviewforLymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study | Full Text | References | PDF (11.9 MB)
  • 1981 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Letter
Interobserver variation among pathologists for delineation of tumor on H&E-sections of laryngeal and hypopharyngeal carcinoma. How good is the gold standard?
Elise Anne Jager, Stefan M. Willems, Tim Schakel, Nina Kooij, Pieter J. Slootweg, Marielle E. P. Philippens, Joana Caldas-Magalhaes, Chris H. J. Terhaard & Cornelis P. J. Raaijmakers
Pages: 391-395
Published online: 13 Jun 2015
First Page PreviewforInterobserver variation among pathologists for delineation of tumor on H&E-sections of laryngeal and hypopharyngeal carcinoma. How good is the gold standard? | Full Text | References | PDF (10.9 MB)
  • 940 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Letter
Second primary malignancy in Burkitt's lymphoma
Binay Kumar Shah & Nibash Budhathoki
Pages: 396-398
Published online: 13 Jun 2015
First Page PreviewforSecond primary malignancy in Burkitt's lymphoma | Full Text | References | PDF (203.8 KB)
  • 1152 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Letter
Syndrome of inappropriate antidiuretic hormone secretion in a patient with castration-resistant prostate cancer treated with enzalutamide
Yoshinori Yanai, Kazuhiro Matsumoto, Naoya Niwa, Takeo Kosaka, Eiji Kikuchi, Akira Miyajima, Hiroshi Ito & Mototsugu Oya
Pages: 399-400
Published online: 16 Jun 2015
CitationforSyndrome of inappropriate antidiuretic hormone secretion in a patient with castration-resistant prostate cancer treated with enzalutamide | Full Text | References | PDF (159.4 KB)
  • 1394 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Explore articles